Isis appoints Dr. Jonas as executive vice president

RSS Feed - Optical News
Carlsbad, CA—Jeffrey M. Jonas, MD, joined Isis Pharmaceuticals Inc. Feb. 1 as executive vice president. He will lead clinical development, preclinical development, regulatory affairs, quality assurance, and compliance at the company. (Source: Ophthalmology Times - Ophthalmic News)